Videos Tu.tv

Aegerion Pharmaceuticals Inc. (Nasdaq:AEGR) Lomitapide 78-Week Phase III Clinical Data Consistent With Earlier Results

Hace más de un año en Noticias y Blogs

304
Enviar a un amigo

Comentarios sobre Aegerion Pharmaceuticals Inc. (Nasdaq:AEGR) Lomitapide 78-Week Phase III Clinical Data Consistent With Earlier Results

Copyright © 2013 HispaVista
Aviso Legal